Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Efficacy and Intermediate Endpoints Assays
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Memphis City Schools: YRBS, HIV Prevention, and Asthma Case Management
Access to Recovery - Iowa, Access to Choice
Minnesota State Heart Disease & Stroke Prevention Program
Substance Abuse and HIV/AIDS Prevention Case Management*
Core - Schizophrenia
Recently added grants:
Computationally Driven Design of De Novo Genetically Encoded Voltage Indicators
California NeuroAIDS Tissue Network
Sleep and Cardiometabolic Health Disparities at the US/Mexico Border: The Nogales Cardiometabolic Health and Sleep (NoCHeS) Study
Biomechanical Determinants of Hematopoietic Stem Cell Potential
HIV-related Stigma and HIV Clinical Outcomes: Linkage and Mechanisms
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN53301-4-0-1
Application #
7587158
Study Section
Project Start
2005-08-30
Project End
2009-08-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Efficacy and Intermediate Endpoints Assays
/ Ohio State University
$1,487,781
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Biomarker Assays
Pereira, Michael /
$1,397,602
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Endpoints Assays
/
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Endpoints Assays
/
Comments
Be the first to comment on this grant